Clinical trial Recruiting at 1 site Observational Ages 60 and up

Digital tools to monitor aging health in rural Taiwan

Official title: Healthy Taiwan Cultivation Plan: Building an Active-ageing Lifestyle in Rural Taiwan Through Integrating Novel Healthcare Technology - From Mitigating Digital and Health Literacy Gap, Establishing a Mobile Interactive Pro-active-ageing Information Platform, to Exploring Multi-dimensional Digital Biomarkers of Ageing

Run by China Medical University Hospital · NCT07232667 · Data updated 2026-11-12

This study tests a wearable and mobile health setup to help understand and support healthy aging in older adults living in Yunlin County, Taiwan.

More Healthy Aging trials

Quick facts

Study typeObservational
Ages60 Years and up
SexAll
Enrollment140 (estimated)
SponsorChina Medical University Hospital
Academic / other
Locations1 site (London, Alabama)
StatusRecruiting
StartedApril 22, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedMay 18, 2026
Trial IDNCT07232667 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Older adults living in rural Yunlin County who are able and willing to participate and provide consent (or have a legally authorized representative).

Probably not a fit

Participants with unstable conditions or skin sensitivities to device materials may not benefit from the wearable components.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational cohort study in Yunlin County aiming to characterize health status, sleep, activity, digital literacy, and dementia-related biomarkers among older adults. It uses a GeneActiv actigraphy device, an AI-supported mobile health platform, and a smart bed sensor to collect data in community and outpatient settings. Data will be analyzed within the Aging Well Taiwan framework and the WHO Integrated Care for Older People framework to standardize assessments of health status, literacy, and functional needs. Phase I (2025–2026) will establish baselines and assess feasibility, usability, and acceptability of wearable and mobile tools, with two weeks of wearables, ICOPE assessments, and blood biomarker collection for dementia-related markers.

Why it matters

Potential benefit: If successful, the study could inform how wearable and digital tools support monitoring and care planning for healthy aging in rural populations.

How similar studies have gone: Previous studies using wearables for aging and digital health literacy support have shown feasibility, though this specific integrated framework in a rural Taiwanese setting is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Currently living or receiving care in a stable environment for at least four weeks prior to enrollment:

   * For community-based participants: must have resided at the same address for ≥4 weeks.
   * For day-care participants: must have attended activities at the same dementia or elderly day-care center for ≥4 weeks.
2. Able and willing to participate in the study procedures.
3. Informed consent must be obtained before participation.

   * If the participant's cognitive function has declined to a level that prevents self-consent, written consent will be obtained from a legally authorized representative or primary caregiver.

Exclusion Criteria:

1. Unstable physical or psychological condition that makes participation unsafe, as determined by a clinical investigator - e.g., acute delirium or current respiratory infection (including COVID-19).
2. Any known allergy or skin sensitivity to the materials used in the Geneactiv actigraphy device or iCue sensor pad.
3. Any other medical, neurological, or behavioral condition deemed unsuitable for participation by the study physician.

Where it's running

  • China Medical University Beigang Hospital
    London, Alabama, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.